Cycle-length evidence
Pinealon cycle length: what human studies ran
Not approved — research use onlyCPreclinical research
Short answer: there is no established Pinealon cycle length or break. The human studies below ran for set periods under monitoring; none tested repeated courses.
Treatment and follow-up in human studies
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Pinealon combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Pinealon cycle length?
No. Human studies administered Pinealon for the periods listed on this page. Those are study durations; none tested an on-and-off schedule or a break.
What is the longest human study of Pinealon?
The durations are listed on this page with their sources; compare them directly rather than relying on a summary.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes Rejuvenation Res. 2011
- Pinealon protects the rat offspring from prenatal hyperhomocysteinemia Int J Clin Exp Med. 2012
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease Molecules. 2020
- Short peptides stimulate serotonin expression in cells of brain cortex Bull Exp Biol Med. 2014
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA Biochemistry (Mosc). 2011
- Drugs@FDA: FDA-Approved Drugs (search of approved applications) FDA Drugs@FDA / openFDA drug/drugsfda. 2026
- DailyMed label search (structured product labels) NLM DailyMed. 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act, updated May 14, 2026 FDA. 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 WADA. 2026
- Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture Bull Exp Biol Med. 2011
- [Analysis of some parameters of biological age and adaptation possibilities of workers of locomotive brigades] Adv Gerontol. 2012
- [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION] Adv Gerontol. 2015
- [Comparative analysis of different methods of geroprotective] Adv Gerontol. 2016
- [The peptide correction of neurotic disorders among professional truck-drivers] Adv Gerontol. 2012